title: Post-traumatic application of brain-derived neurotrophic factor and glia-derived neurotrophic factor on the rat spinal cord enhances neuroprotection and improves motor function.
abstract: We examined the potential efficacy of brain-derived neurotrophic factor (BDNF) and glial-derived neurotrophic factor (GDNF) applied over traumatized spinal cord, alone or in combination, for attenuating motor dysfunction, blood-spinal cord barrier (BSCB) breakdown, edema formation, and cell injury in a rat model. Under Equithesin anesthesia, spinal cord injury (SCI) was performed by making a unilateral incision into the right dorsal horn of the T10-11 segment. The rats were allowed to survive 5 hours after trauma. The BDNF or GDNF was applied (0.1 to 1 microg/10 microl in phosphate buffer saline) 30, 60, or 90 minutes after SCI. Topical application of BDNF or GDNF 30 minutes after SCI in high concentration (0.5 microg and 1 microg) significantly improved motor function and reduced BSCB breakdown, edema formation, and cell injury at 5 hours. These beneficial effects of neurotrophins were markedly absent when administered separately either 60 or 90 minutes after injury. However, combined application of BDNF and GDNF at 60 or 90 minutes after SCI resulted in a significant reduction in motor dysfunction and spinal cord pathology. These novel observations suggest that neurotrophins in combination have potential therapeutic value for the treatment of SCI in clinical situations.
authors: Laboratory of Cerebrovascular Biology, Department of Surgical Sciences, Anesthesiology and Intensive Care Medicine, University Hospital, Uppsala University, Uppsala, Sweden. Sharma@surgsci.uu.se
authors: H S
authors: HS
authors: Sharma